Compare Novavax Inc (NVAX) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Novavax Inc trades at $8.12 (market cap $1.30B), while YieldMax Universe Fund of Option Income ETFs trades at $7.66. The key difference: Novavax Inc is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| NVAX | YMAX | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $11.19 | $14.00 |
52-Week Low | $6.22 | $7.51 |
Enterprise Value | $800.50M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
YMAX trades at $7.52 with no recent price movement. Technical indicators show a bearish trend with moving averages signaling sell and oscillators neutral. The stock faces significant resistance at $8 and support at $7. Recent news highlights concerns over shrinking dividends and layered fees in its fund-of-funds structure, impacting investor returns.
The outlook for YMAX is cautious due to declining dividend payouts and high fee structure risks. While oversold RSI levels may offer short-term bounce potential, fundamental data is unavailable, and sentiment is negative. Investors should weigh income erosion against technical oversold conditions before considering entry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
